Action NOVARTIS AG
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Société Novartis AG Swiss Exchange

Actions

CH0012005267

Produits pharmaceutiques

Temps réel estimé Cboe Europe
Autres places de cotation
 17:20:00 26/06/2024
95,91 CHF 0,00% Graphique intraday de Novartis AG
09:40 Bourse Zurich: bonne ambiance dans la foulée du rebond technologique AW
25/06 Bourse Zurich: dans le rouge au lendemain d'une belle progression AW

Métier

Novartis AG figure parmi les leaders mondiaux de la conception, de la fabrication et de la commercialisation de produits pharmaceutiques. Le CA (hors activités abandonnées) par domaine thérapeutique se répartit comme suit :

- oncologie (29,9%) ;

- immunologie (17,2%) ;

- maladies cardio-vasculaires, rénales et métaboliques (14,1%) ;

- neuroscience (8,9%) ;

Le solde du CA (29,9%) concerne l'activité de fabrication en sous-traitance de produits pharmaceutiques.

A fin 2023, Novartis AG dispose de 33 sites de production dans le monde.

La répartition géographique du CA est la suivante : Europe (33%), Etats-Unis (39,5%), Asie-Afrique-Australasie (20,5%), Canada et Amérique latine (7%).

Ventes par activité

CHF en Millions2022Poids2023Poids Delta
Established Brands
30,0 %
- - 12 238 30,0 % -
Oncology
29,9 %
- - 12 213 29,9 % -
Immunology
17,2 %
- - 7 008 17,2 % -
Cardiovascular, Renal and Metabolic
14,1 %
- - 5 743 14,1 % -
Neuroscience
8,9 %
- - 3 633 8,9 % -

Ventes par région

CHF en Millions2022Poids2023Poids Delta
United States
39,5 %
16 860 34,9 % 16 139 39,5 % -4,28%
Europe
18,9 %
10 469 21,7 % 7 704 18,9 % -26,41%
Asia/Africa/Australasia
9,1 %
4 975 10,3 % 3 700 9,1 % -25,63%
Germany
7,4 %
4 086 8,5 % 3 026 7,4 % -25,94%
China
7,2 %
2 987 6,2 % 2 936 7,2 % -1,73%
Canada and Latin America
7,0 %
3 709 7,7 % 2 854 7,0 % -23,04%
Japan
4,2 %
2 106 4,4 % 1 729 4,2 % -17,90%
France
3,8 %
2 156 4,5 % 1 572 3,8 % -27,09%
Switzerland
2,9 %
926 1,9 % 1 175 2,9 % +26,88%

Dirigeants

Dirigeants TitreAgeDepuis
Vasant Narasimhan CEO
 Chief Executive Officer 48 01/01/05
Harry Werner Kirsch DFI
 Director of Finance/CFO 59 01/01/03
Shreeram Aradhye CTO
 Chief Tech/Sci/R&D Officer 62 16/05/22
Steffen Lang COO
 Chief Operating Officer 57 01/04/17
Klaus Moosmayer CMP
 Compliance Officer 56 01/12/18
Samir Shah IRO
 Public Communications Contact 63 01/01/04
Simon Brown PRN
 Corporate Officer/Principal - 01/08/13
Kees Roks AUD
 Comptroller/Controller/Auditor 61 01/05/22
Linda Kanitra PRN
 Corporate Officer/Principal - -
Robert Kowalski HRO
 Human Resources Officer 56 01/09/21

Administrateurs

Administrateurs TitreAgeDepuis
Bill Winters BRD
 Director/Board Member 62 01/01/13
Simon Moroney BRD
 Director/Board Member 65 28/02/20
Hans Jörg Reinhardt CHM
 Chairman 68 01/01/13
John Young BRD
 Director/Board Member 60 07/03/23
Bridgette Heller BRD
 Director/Board Member 62 28/02/20
Ton Büchner BRD
 Director/Board Member 59 01/01/16
Charles Sawyers BRD
 Director/Board Member 65 01/01/13
Nancy Andrews BRD
 Director/Board Member 65 01/01/15
Patrice Bula BRD
 Director/Board Member 68 28/02/19
Frans van Houten BRD
 Director/Board Member 64 28/02/17

Classe d'actions

VoteNombreFlottantAutocontrôleFlottant Total
Action A 1 2 189 930 497 1 866 336 959 ( 85,22 %) 233 443 766 ( 10,66 %) 85,22 %

Actionnaires

NomActions%Valorisation
NOVARTIS AG
6,625 %
145 083 991 6,625 % 14 984 M CHF
Sandoz Family Foundation
4,070 %
89 135 960 4,070 % 9 206 M CHF
UBS Asset Management Switzerland AG
3,123 %
68 391 910 3,123 % 7 063 M CHF
MFS International Singapore Pte Ltd.
0,1785 %
3 909 515 0,1785 % 404 M CHF
MFS International (UK) Ltd.
0,1767 %
3 870 492 0,1767 % 400 M CHF
State Street Global Advisors Ltd.
0,1654 %
3 622 744 0,1654 % 374 M CHF
Sjunde AP-fonden
0,1384 %
3 031 826 0,1384 % 313 M CHF
Eleva Capital LLP
0,1355 %
2 967 691 0,1355 % 306 M CHF
Barings (UK) Ltd.
0,1310 %
2 868 212 0,1310 % 296 M CHF
Amundi Asset Management SA (Investment Management)
0,1087 %
2 379 602 0,1087 % 246 M CHF
NomActions%Valorisation
PRIMECAP Management Co.
0,5670 %
12 417 755 0,5670 % 1 281 M CHF
Dodge & Cox
0,5641 %
12 353 985 0,5641 % 1 274 M CHF
Eaton Vance Management
0,3314 %
7 258 381 0,3314 % 749 M CHF
Loomis, Sayles & Co. LP
0,2702 %
5 917 972 0,2702 % 610 M CHF
DFA Australia Ltd.
0,2624 %
5 747 215 0,2624 % 593 M CHF
Fiduciary Trust Company International
0,2603 %
5 700 550 0,2603 % 588 M CHF
U.S. Trust Company of Delaware
0,2273 %
4 977 839 0,2273 % 513 M CHF
Wellington Management Co. LLP
0,2096 %
4 589 350 0,2096 % 473 M CHF
Wells Fargo Bank NA
0,1826 %
3 997 877 0,1826 % 412 M CHF
The Ayco Co. LP
0,1397 %
3 059 361 0,1397 % 316 M CHF
NomActions%Valorisation
LUKB Expert Fondsleitung AG
-
64 694 - 7 M CHF
Swiss Rock Asset Management AG
-
19 614 - 2 M CHF

Participations

NomActions%Valorisation
NOVARTIS AG
6,63%
 145 083 991 6,63% 14 983 623 163 $
MORPHOSYS AG
51,00%
 19 235 376 51,00% 1 433 544 095 $
SANDOZ GROUP AG
2,99%
 12 886 900 2,99% 457 966 018 $
NOVARTIS INDIA LIMITED
70,68%
 17 450 680 70,68% 218 239 949 $
THIRD HARMONIC BIO, INC.
6,45%
 2 642 762 6,45% 35 175 162 $
ERASCA, INC.
4,74%
 12 307 692 4,74% 31 015 384 $
OCULIS HOLDING AG
4,66%
 1 713 521 4,66% 20 151 007 $
MOLECULAR PARTNERS AG
4,74%
 1 739 130 4,74% 6 554 381 $
PRECISION BIOSCIENCES, INC.
5,97%
 413 581 5,97% 5 335 195 $

Coordonnées société

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com
Adresse Novartis AG

Sociétés du groupe

NomCatégorie et Secteur
Novartis Healthcare Pvt Ltd.
Logo Novartis Healthcare Pvt Ltd.

Novartis Healthcare Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar.

Pharmaceuticals: Major
Novartis Pharma AG
Logo Novartis Pharma AG

Novartis Pharma AG

Pharmaceuticals: MajorHealth Technology

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Pharmaceuticals: Major
Novartis Investment Ltd.
Novartis Holding AG
Logo Novartis Holding AG

Novartis Holding AG

Financial ConglomeratesFinance

Part of Novartis AG, Novartis Holding AG is a Swiss healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Basel, Switzerland. Novartis Holding specializes in Managed Access Programs and is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment.

Financial Conglomerates
Novartis International AG
Logo Novartis International AG

Novartis International AG

Pharmaceuticals: MajorHealth Technology

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Pharmaceuticals: Major
Novartis Services, Inc.
Novartis Finance SA
Finance/Rental/Leasing
Novartis BioVenturesAG
Logo Novartis BioVenturesAG

Novartis BioVenturesAG

Investment ManagersFinance

Part of Novartis AG, Novartis BioVenturesAG is an alternative investment manager. The company is based in Basel, Switzerland.

Investment Managers
Novartis Investments SARL
Logo Novartis Investments SARL

Novartis Investments SARL

Financial ConglomeratesFinance

Novartis Investments SARL is an investment holding company with interest in medicines and pharmaceuticals sector. The company was founded on July 05, 2002 and is headquartered in Luxembourg.

Financial Conglomerates

Secteur

Santé
Recherche pharmaceutique et médicale
Produits pharmaceutiques
Produits pharmaceutiques
Pharmacies - Autres

Ventes par activité

Ventes par région

Secteur Pharmacies - Autres

Varia. 1 janv. Capi.
ELI LILLY AND COMPANY Action Eli Lilly and Company
+55,08% 815 Md
NOVO NORDISK A/S Action Novo Nordisk A/S
+44,25% 654 Md
JOHNSON & JOHNSON Action Johnson & Johnson
-6,49% 354 Md
MERCK & CO., INC. Action Merck & Co., Inc.
+21,68% 337 Md
ABBVIE INC. Action AbbVie Inc.
+10,35% 302 Md
ASTRAZENECA PLC Action AstraZeneca PLC
+18,11% 247 Md
ROCHE HOLDING AG Action Roche Holding AG
+2,33% 229 Md
AMGEN INC. Action Amgen Inc.
+9,46% 171 Md
PFIZER, INC. Action Pfizer, Inc.
-3,35% 159 Md
Pharmacies - Autres
  1. Bourse
  2. Actions
  3. Action NOVN
  4. Action
  5. Société Novartis AG